443 related articles for article (PubMed ID: 17875951)
1. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
[TBL] [Abstract][Full Text] [Related]
2. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
Chow SL; Peng JT; Okamoto MP; Heywood JT
Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
[TBL] [Abstract][Full Text] [Related]
4. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
Arora S; Clarke K; Srinivasan V; Gradman A
QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
6. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
[TBL] [Abstract][Full Text] [Related]
7. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
8. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
Yancy CW; Singh A
Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
[TBL] [Abstract][Full Text] [Related]
9. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
10. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
11. Nesiritide in the initial management of acute decompensated congestive heart failure.
Sakr A; Hahn P; Donohue T; Ghantous A
Conn Med; 2008 Oct; 72(9):517-23. PubMed ID: 18833867
[TBL] [Abstract][Full Text] [Related]
12. Intravenous nesiritide in acute heart failure.
Knox MA; Dancy T; Mook W; Pschirer JJ
Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure.
Bartone C; Saghir S; Menon SG; Brosmer J; Kereiakes DJ; Mazur W; Chung ES
Congest Heart Fail; 2008; 14(6):298-301. PubMed ID: 19076851
[TBL] [Abstract][Full Text] [Related]
14. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
[TBL] [Abstract][Full Text] [Related]
15. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
16. Nesiritide: past, present, and future.
Burger AJ; Burger MR
Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
[TBL] [Abstract][Full Text] [Related]
18. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
19. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
[TBL] [Abstract][Full Text] [Related]
20. BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department.
Chandra A; Otero R; Freeman D; Cairns CB
Ren Fail; 2008; 30(1):45-50. PubMed ID: 18197542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
